Skip to main content

Table 3 Comparisons between adult patients infected with T6SS-positive and T6SS-negative C. jejuni

From: Clinical impact of the type VI secretion system on virulence of Campylobacter species during infection

 

T6SS-positive

T6SS-negative

p-value

(n = 20)

(n = 99)

Baseline characteristics

   

Age (median years)

58 (46–77)

57 (31–74)

n.s.

Male gender

13 (65.0)

61 (61.6)

n.s.

Hospitalised patients

12 (60.0)

61 (61.6)

n.s.

Duration of hospital stay (median days)

3 (0–5)

1 (0–5)

n.s.

ICU stay (yes)

1 (5.0)

1 (1.0)

n.s.

Comorbidities

   

Charlson Comorbidity Index

2 (1–5)

0 (0–1)

< 0.001

Solid organ transplant

4 (20.0)

3 (3.0)

0.015

Immunosuppressant therapy

6 (30.0)

9 (9.1)

0.019

Clinical characteristics

   

Bacteraemia

0 (0.0)

6 (6.1)

n.s.

Fever history (yes)

6 (30.0)

56 (56.6)

0.048

Bloody diarrhoea (yes)

2 (10.0)

19 (19.2)

n.s.

Duration of diarrhoea (days)

6 (4–10)

6 (4–9)

n.s.

Leucocytes (× 109/l)

8.5 (6.1–12.1)

8.7 (5.9–11.1)

n.s.

Antibiotic therapy (yes)

13 (65.0)

60 (60.6)

n.s.

  1. Data are median (IQR) or n (%). P values ≤0.05 are shown. Only p-values of significant results were shown. n.s. non-significant